305 related articles for article (PubMed ID: 24968947)
1. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
2. Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer.
Matsumoto K; Irie A; Satoh T; Ishii J; Iwabuchi K; Iwamura M; Egawa S; Baba S
Urology; 2007 Sep; 70(3):602-7. PubMed ID: 17688917
[TBL] [Abstract][Full Text] [Related]
3. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer.
Kim JH; Park J
Hum Pathol; 2014 Sep; 45(9):1830-8. PubMed ID: 24957789
[TBL] [Abstract][Full Text] [Related]
5. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.
Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J
APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
7. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy.
Jin L; Shen Q; Ding S; Jiang W; Jiang L; Zhu X
Gynecol Oncol; 2012 Jul; 126(1):140-6. PubMed ID: 22487537
[TBL] [Abstract][Full Text] [Related]
9. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
10. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
12. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
13. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma.
Shah CH; Viktorsson K; Kanter L; Sherif A; Asmundsson J; Rosenblatt R; Lewensohn R; Ullén A
Urol Oncol; 2014 Nov; 32(8):1215-24. PubMed ID: 24880461
[TBL] [Abstract][Full Text] [Related]
16. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
[TBL] [Abstract][Full Text] [Related]
17. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
18. Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients.
Agerbaek M; Alsner J; Marcussen N; Lundbeck F; Von der Maase H
Eur Urol; 2006 Oct; 50(4):777-85. PubMed ID: 16632178
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma.
Chong HI; Lee JH; Yoon MS; Suh DS; Kim K; Kim JY; Choi KU
Oncol Rep; 2014 Jun; 31(6):2701-7. PubMed ID: 24756855
[TBL] [Abstract][Full Text] [Related]
20. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
